404 results on '"Foltynie, Tom"'
Search Results
2. Effects of deep brain stimulation frequency on eye movements and cognitive control
3. Medical, surgical, and physical treatments for Parkinson's disease
4. Mechanisms Underlying Decision-Making as Revealed by Deep-Brain Stimulation in Patients with Parkinson’s Disease
5. Advantages and Challenges of Platform Trials for Disease Modifying Therapies in Parkinson's Disease.
6. Identification of nonlinear features in cortical and subcortical signals of Parkinson's Disease patients via a novel efficient measure
7. Ropinirole, a dopamine agonist with high D3 affinity, reduces proactive inhibition: A double-blind, placebo-controlled study in healthy adults
8. Resting state activity and connectivity of the nucleus basalis of Meynert and globus pallidus in Lewy body dementia and Parkinson's disease dementia
9. Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson’s disease
10. Neural signatures of hyperdirect pathway activity in Parkinson’s disease
11. L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression
12. A Randomized Trial Directly Comparing Ventral Capsule and Anteromedial Subthalamic Nucleus Stimulation in Obsessive-Compulsive Disorder: Clinical and Imaging Evidence for Dissociable Effects
13. Long-term outcomes of deep brain stimulation in Parkinson disease
14. Improving conversations about Parkinson’s dementia
15. Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
16. Utility of the new Movement Disorder Society clinical diagnostic criteria for Parkinson's disease applied retrospectively in a large cohort study of recent onset cases
17. Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience
18. Reducing the number of patients needed in disease modifying trials for parkinsonian disorders
19. Chapter 6 - Clinical/surgical considerations
20. Subthalamic nucleus phase–amplitude coupling correlates with motor impairment in Parkinson’s disease
21. Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease
22. Analysis of simultaneous MEG and intracranial LFP recordings during Deep Brain Stimulation: a protocol and experimental validation
23. Confusion of Evidence-Based Reviews and Guidelines
24. Confusion of evidence‐based reviews and guidelines
25. Modulation of limbic resting-state networks by subthalamic nucleus deep brain stimulation
26. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed–accuracy instructions
27. 11C‐PE2I and 18F‐Dopa PET for assessing progression rate in Parkinsonʼs: A longitudinal study
28. PO088 Nigral iron susceptibility in parkinson’s disease: a longitudinal study
29. Pathophysiological heterogeneity in Parkinsonʼs disease: Neurophysiological insights from LRRK2 mutations
30. 109 Embedding patient voice in trial design: the EJS ACT-PD experience
31. Neurofilament light levels predict clinical progression and death in multiple system atrophy
32. Effects of deep brain stimulation frequency on eye movements and cognitive control
33. European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies
34. Reply to: Cognitive Effects of Deep Brain Stimulation inGBA‐Related Parkinson's Disease
35. Neurosurgery for cognitive disorders
36. A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive-compulsive disorder : Clinical and imaging evidence for dissociable effects
37. EAN/MDS-ES guideline on the treatment of Parkinson’s Disease: I. Invasive therapies
38. European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies
39. Gender distribution of patients with Parkinson’s disease treated with subthalamic deep brain stimulation; a review of the 2000–2009 literature
40. 233 Working towards an adaptive trial platform for Parkinson’s disease
41. Functional Connectivity of the Pedunculopontine Nucleus and Surrounding Region in Parkinsonʼs Disease
42. Deep brain stimulation modulates synchrony within spatially and spectrally distinct resting state networks in Parkinson’s disease
43. Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects inGBAMutation Carriers
44. A Randomized Trial Directly Comparing Ventral Capsule and Anteromedial Subthalamic Nucleus Stimulation in Obsessive-Compulsive Disorder: Clinical and Imaging Evidence for Dissociable Effects
45. Parkinson’s disease: an update on pathogenesis and treatment
46. Value of subthalamic nucleus local field potentials recordings in predicting stimulation parameters for deep brain stimulation in Parkinson's disease
47. Not only loud but also intelligible
48. Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
49. Predictive Factors of Speech Intelligibility Following Subthalamic Nucleus Stimulation in Consecutive Patients With Parkinsonʼs Disease
50. Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on ‘effective’ connectivity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.